766-55-2,MFCD07782103
Catalog No.:AA003QWU

766-55-2 | Imidazo[1,2-b]pyridazine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
95%
in stock  
$8.00   $6.00
- +
5g
95%
in stock  
$11.00   $8.00
- +
25g
95%
in stock  
$30.00   $21.00
- +
100g
95%
in stock  
$117.00   $82.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA003QWU
Chemical Name:
Imidazo[1,2-b]pyridazine
CAS Number:
766-55-2
Molecular Formula:
C6H5N3
Molecular Weight:
119.1240
MDL Number:
MFCD07782103
SMILES:
c1cnn2c(c1)ncc2
Properties
Properties
 
Form:
Solid  
MP:
47 - 50 °C  
Solubility:
Soluble in dimethylformamide.  
Storage:
Inert atmosphere;Room Temperature;  

Computed Properties
 
Complexity:
105  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
0  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
0.3  

Literature

Title: Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors. 1. Exploration of [5,6]-fused bicyclic scaffolds.

Journal: Journal of medicinal chemistry 20120412

Title: Discovery of imidazo[1,2-b]pyridazines as IKKβ inhibitors. Part 3: exploration of effective compounds in arthritis models.

Journal: Bioorganic & medicinal chemistry letters 20110801

Title: Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia.

Journal: Blood 20110721

Title: Biochemical characterization of TAK-593, a novel VEGFR/PDGFR inhibitor with a two-step slow binding mechanism.

Journal: Biochemistry 20110208

Title: Discovery of imidazo[1,2-b]pyridazines as IKKβ inhibitors. Part 2: improvement of potency in vitro and in vivo.

Journal: Bioorganic & medicinal chemistry letters 20110201

Title: Urocortin-1 within the centrally-projecting Edinger-Westphal nucleus is critical for ethanol preference.

Journal: PloS one 20110101

Title: Discovery of imidazo[1,2-b]pyridazine derivatives as IKKbeta inhibitors. Part 1: Hit-to-lead study and structure-activity relationship.

Journal: Bioorganic & medicinal chemistry letters 20100901

Title: Inhibitors of PIM-1 kinase: a computational analysis of the binding free energies of a range of imidazo [1,2-b] pyridazines.

Journal: Journal of chemical information and modeling 20100322

Title: Intra-periaqueductal grey microinjections of an imidazo[1,2-b]pyridazine derivative, DM2, affects rostral ventromedial medulla cell activity and shows antinociceptive effect.

Journal: Neuropharmacology 20100301

Title: Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells.

Journal: Blood 20091105

Title: Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation.

Journal: Structure (London, England : 1993) 20090311

Title: T-type channel blocking properties and antiabsence activity of two imidazo[1,2-b]pyridazine derivatives structurally related to indomethacin.

Journal: Neuropharmacology 20090301

Title: Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitors.

Journal: Bioorganic & medicinal chemistry letters 20040503

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:766-55-2 Molecular Formula|766-55-2 MDL|766-55-2 SMILES|766-55-2 Imidazo[1,2-b]pyridazine
Catalog No.: AA003QWU
766-55-2,MFCD07782103
766-55-2 | Imidazo[1,2-b]pyridazine
Pack Size: 1g
Purity: 95%
in stock
$8.00 $6.00
Pack Size: 5g
Purity: 95%
in stock
$11.00 $8.00
Pack Size: 25g
Purity: 95%
in stock
$30.00 $21.00
Pack Size: 100g
Purity: 95%
in stock
$117.00 $82.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA003QWU
Chemical Name: Imidazo[1,2-b]pyridazine
CAS Number: 766-55-2
Molecular Formula: C6H5N3
Molecular Weight: 119.1240
MDL Number: MFCD07782103
SMILES: c1cnn2c(c1)ncc2
Properties
Form: Solid  
MP: 47 - 50 °C  
Solubility: Soluble in dimethylformamide.  
Storage: Inert atmosphere;Room Temperature;  
Complexity: 105  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 9  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 0  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 0.3  
Literature fold

Title: Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors. 1. Exploration of [5,6]-fused bicyclic scaffolds.

Journal: Journal of medicinal chemistry20120412

Title: Discovery of imidazo[1,2-b]pyridazines as IKKβ inhibitors. Part 3: exploration of effective compounds in arthritis models.

Journal: Bioorganic & medicinal chemistry letters20110801

Title: Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia.

Journal: Blood20110721

Title: Biochemical characterization of TAK-593, a novel VEGFR/PDGFR inhibitor with a two-step slow binding mechanism.

Journal: Biochemistry20110208

Title: Discovery of imidazo[1,2-b]pyridazines as IKKβ inhibitors. Part 2: improvement of potency in vitro and in vivo.

Journal: Bioorganic & medicinal chemistry letters20110201

Title: Urocortin-1 within the centrally-projecting Edinger-Westphal nucleus is critical for ethanol preference.

Journal: PloS one20110101

Title: Discovery of imidazo[1,2-b]pyridazine derivatives as IKKbeta inhibitors. Part 1: Hit-to-lead study and structure-activity relationship.

Journal: Bioorganic & medicinal chemistry letters20100901

Title: Inhibitors of PIM-1 kinase: a computational analysis of the binding free energies of a range of imidazo [1,2-b] pyridazines.

Journal: Journal of chemical information and modeling20100322

Title: Intra-periaqueductal grey microinjections of an imidazo[1,2-b]pyridazine derivative, DM2, affects rostral ventromedial medulla cell activity and shows antinociceptive effect.

Journal: Neuropharmacology20100301

Title: Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells.

Journal: Blood20091105

Title: Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation.

Journal: Structure (London, England : 1993)20090311

Title: T-type channel blocking properties and antiabsence activity of two imidazo[1,2-b]pyridazine derivatives structurally related to indomethacin.

Journal: Neuropharmacology20090301

Title: Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitors.

Journal: Bioorganic & medicinal chemistry letters20040503

Building Blocks More >
25103-09-7
25103-09-7
6-Methylheptyl 2-mercaptoacetate
AA003R1B | MFCD00022088
2219-31-0
2219-31-0
Dl-canavanine sulfate
AA003R5T | MFCD00012618
1086-80-2
1086-80-2
7,8-dimethyl-1H,2H,3H,4H-benzo[g]pteridine-2,4-dione
AA003RAY | MFCD00005021
95715-86-9
95715-86-9
(R)-(-)-3-BOC-4-methoxycarbonyl-2,2-dimethyl-1,3-oxazolidine
AA003RGB | MFCD00674041
1133115-93-1
1133115-93-1
Methyl 2-amino-4-(3-bromophenyl)pyrimidine-5-carboxylate
AA003RJQ | MFCD11855912
1423134-61-5
1423134-61-5
Methyl 3-(boc-amino)-3-(3-hydroxyphenyl)propanoate
AA003RMX | MFCD27935388
2177-78-8
2177-78-8
Methyl 3-methylpentanoate
AA003RQD | MFCD00024619
2144-37-8
2144-37-8
Methyl 5-(chloromethyl)-2-furoate
AA003RTW | MFCD00020922
2733-88-2
2733-88-2
NERVONIC ACID METHYL ESTER
AA003RX4 | MFCD00056324
109-82-0
109-82-0
Methylenaminoacetonitrile
AA003S0Y | MFCD00001889
Submit
© 2017 AA BLOCKS, INC. All rights reserved.